Medtronic plc Files 8-K: Material Agreement Details
Ticker: MDT · Form: 8-K · Filed: 2025-09-29T00:00:00.000Z
Sentiment: neutral
Topics: material-agreement, 8-K, debt-filing
Related Tickers: MDT
TL;DR
Medtronic signed a big deal, filing an 8-K on 9/29/25. Details to come.
AI Summary
On September 29, 2025, Medtronic plc filed an 8-K detailing a material definitive agreement. The filing also includes other events and financial statements/exhibits. Specific details regarding the agreement, such as parties involved and financial terms, are not fully elaborated in the provided text.
Why It Matters
This filing indicates a significant new agreement for Medtronic, which could impact its business operations, financial standing, and future strategic direction.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which could carry significant financial or operational implications for Medtronic, but the specific nature of the agreement is not detailed.
Key Numbers
- 0001613103 — Central Index Key (Medtronic's unique identifier with the SEC)
Key Players & Entities
- Medtronic plc (company) — Filer
- 0001193125-25-221819 (document_id) — Accession Number
- 20250929 (date) — Filing Date
FAQ
What is the nature of the material definitive agreement entered into by Medtronic plc?
The provided text does not specify the details of the material definitive agreement, only that one was entered into on or before September 29, 2025.
What are the specific financial terms or dollar amounts associated with the material definitive agreement?
The provided text does not contain specific dollar amounts or financial terms related to the material definitive agreement.
Who are the other parties involved in the material definitive agreement with Medtronic plc?
The filing does not disclose the names of the other parties involved in the material definitive agreement.
What is the purpose or business objective of the material definitive agreement?
The purpose or business objective of the material definitive agreement is not detailed in the provided excerpt of the 8-K filing.
When was the material definitive agreement officially entered into?
The filing indicates the report date as September 29, 2025, and the date as of change is also September 29, 2025, suggesting the agreement was finalized around this date.
From the Filing
0001193125-25-221819.txt : 20250929 0001193125-25-221819.hdr.sgml : 20250929 20250929084528 ACCESSION NUMBER: 0001193125-25-221819 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 23 CONFORMED PERIOD OF REPORT: 20250929 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250929 DATE AS OF CHANGE: 20250929 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 FISCAL YEAR END: 0424 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 251352390 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY PROVINCE COUNTRY: L2 ZIP: H91 4K49 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY PROVINCE COUNTRY: L2 ZIP: H91 4K49 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K 1 d73148d8k.htm 8-K 8-K 0001613103 H91 VY19 false 0001613103 2025-09-29 2025-09-29 0001613103 us-gaap:CommonStockMember 2025-09-29 2025-09-29 0001613103 mdt:A0.000SeniorNotesDue2025Member 2025-09-29 2025-09-29 0001613103 mdt:A2.625SeniorNotesDue2025Member 2025-09-29 2025-09-29 0001613103 mdt:A1.125SeniorNotesDue2027Member 2025-09-29 2025-09-29 0001613103 mdt:A0.375SeniorNotesDue2028Member 2025-09-29 2025-09-29 0001613103 mdt:A3.000SeniorNotesDue2028Member 2025-09-29 2025-09-29 0001613103 mdt:A3.650SeniorNotesDue2029Member 2025-09-29 2025-09-29 0001613103 mdt:A1.625SeniorNotesDue2031Member 2025-09-29 2025-09-29 0001613103 mdt:A1.000SeniorNotesDue2031Member 2025-09-29 2025-09-29 0001613103 mdt:A3.125SeniorNotesDue2031Member 2025-09-29 2025-09-29 0001613103 mdt:A0.750SeniorNotesDue2032Member 2025-09-29 2025-09-29 0001613103 mdt:A3.375SeniorNotesDue2034Member 2025-09-29 2025-09-29 0001613103 mdt:A3.875SeniorNotesDue2036Member 2025-09-29 2025-09-29 0001613103 mdt:A2.250SeniorNotesDue2039Member 2025-09-29 2025-09-29 0001613103 mdt:A1.500SeniorNotesDue2039Member 2025-09-29 2025-09-29 0001613103 mdt:A1.375SeniorNotesDue2040Member 2025-09-29 2025-09-29 0001613103 mdt:A4.150SeniorNotesDue2043Member 2025-09-29 2025-09-29 0001613103 mdt:A1.750SeniorNotesDue2049Member 2025-09-29 2025-09-29 0001613103 mdt:A1.625SeniorNotesDue2050Member 2025-09-29 2025-09-29 0001613103 mdt:A4.150SeniorNotesDue2053Member 2025-09-29 2025-09-29     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2025     Medtronic plc (Exact Name of Registrant as Specified in its Charter)       Ireland   1-36820   98-1183488 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) Building Two Parkmore Business Park West Galway , Ireland (Address of principal executive offices) + 353 1 438-1700 (Registrant’s telephone number, including area code) Not Applicable Former name or former address, if changed since last report     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR